Hyoung Jin Kang, MD, PhD
Articles
Dr. Kang on Aprepitant for Preventing CINV in Children
July 03, 2014
Article
Hyoung Jin Kang, MD, PhD, associate professor, Department of Pediatrics, Seoul National University, South Korea, discusses a phase III trial of aprepitant for chemotherapy-induced nausea and vomiting (CINV) in children.